PROKIDNEY CORP.
For the period ended Aug 10, 2026. Filed Aug 10, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Aug 10, 2026 · Filed Aug 10, 2026
Use the contents to explore the available documents and sections.
PROK$1.14+7.0%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (in thousands, except for share data)
(in thousands, except for share data)
| June 30, 2026 | December 31, 2025 | |
|---|---|---|
| (Unaudited) | ||
| Assets | ||
| Cash and cash equivalents | $74,868 | $108,537 |
| Marketable securities | 106,696 | 161,480 |
| Interest receivable | 956 | 1,127 |
| Prepaid assets | 2,827 | 2,808 |
| Prepaid clinical | 3,649 | 3,923 |
| Other current assets | 772 | 2,804 |
| Total current assets | 189,768 | 280,679 |
| Fixed assets, net | 56,037 | 51,231 |
| Right of use assets, net | 3,211 | 3,664 |
| Total assets | $249,016 | $335,574 |
| Liabilities and Stockholders' Deficit | ||
| Accounts payable | $1,610 | $940 |
| Lease liabilities | 1,129 | 1,071 |
| Accrued expenses and other | 19,971 | 28,731 |
| Total current liabilities | 22,710 | 30,742 |
| Income tax payable, net of current portion | 1,074 | 1,074 |
| Lease liabilities, net of current portion | 2,394 | 2,965 |
| Total liabilities | 26,178 | 34,781 |
| Commitments and contingencies | ||
| Redeemable noncontrolling interest | 1,106,370 | 1,311,990 |
| Stockholders’ deficit | ||
| Class A common stock, $0.0001 par value; 700,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 205,716,189 and 141,807,277 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 21 | 14 |
| Class B common stock, $0.0001 par value; 500,000,000 shares authorized; 96,596,315 and 159,262,779 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 10 | 16 |
| Additional paid-in capital | 434,765 | 258,552 |
| Accumulated other comprehensive (loss) gain | (34) | 56 |
| Accumulated deficit | (1,318,294) | (1,269,835) |
| Total stockholders' deficit | (883,532) | (1,011,197) |
| Total liabilities and stockholders' deficit | $249,016 | $335,574 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.